Abstract
A single cross-sectional study for serum copper and zinc levels was evaluated in 20 patients with cancer (respiratory, digestive, haematological, gynaecological) and 21 patients with cardiopathy (acute myocardial infarction and ischemic cardiomyopathy). A control group of 84 healthy subjects was selected. The mean serum zinc levels in patients with gynaecological cancer and ischemic cardiomyopathy were significantly lower than the control group ( P < 0.05). However, the mean serum copper level was not statistically different among patients with cancer ( P > 0.05) and cardiomyopathy ( P > 0.05) than the control group. Male patients did not have statistically different values for serum Cu ( P > 0.05) and Zn ( P > 0.05) than those found in female patients. Patients' age did not have any statistical influence ( P > 0.05) on serum Cu and Zn levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
